Profile banner
Ravi Ramenani

Ravi Ramenani

Scientist • Product • Founder

San Diego, California, United States
Joined January 2025

Network

1.2K connections
👔
Biotech & Genomics Executives
📈
Biotech Commercial & Product Leaders
💻
Software & Tech Engineering Leaders
🧪
Biotech & Genomics Scientists
📊
Genomics & Bioinformatics Specialists
💡
Biotech Startup Founders
🧬
10x Genomics

Summary

Ravi Ramenani is an experienced scientist and entrepreneur in the biotechnology and genomics fields, with a strong background in single-cell genomics, antibody discovery, and product marketing. He has worked at prominent companies such as Berkeley Lights and 10x Genomics, and co-founded Zafrens, a company focused on single-cell multi-omics analysis. tracxn
He is an inventor on multiple patents related to advanced biotechnological assays and methods, including compositions and methods for characterizing binding characteristics of antigen binding molecules from single cells, capture beads, perturbation beads, and methods for epitope binning of monoclonal antibodies. This demonstrates his innovative contributions to the field. justia+5
His scientific contributions include co-authorship on significant research papers such as 'Rapid single B cell antibody discovery using nanopens and structured light,' published in mAbs, and a highly cited Nature paper from 'The 1000 Genomes Project,' focusing on human genome variation. tandfonline+2
Ravi has a strong academic foundation with a Master of Science in Biochemistry from the University of Houston and a Bachelor of Technology in Biotechnology from Anna University, which underpins his extensive career in scientific research and product development. researchgate

Work

Education

Writing

COMPOSITIONS AND METHODS FOR CHARACTERIZING BINDING CHARACTERISTICS OF ANTIGEN BINDING MOLECULES FROM SINGLE CELLS

May 1, 2025

A patent application related to methods for analyzing antigen binding molecules at a single-cell level.

Favicon imagepatents.justia.com

Capture Beads for Use in Assays

November 1, 2024

A patent application for capture bead technology used in various assays.

Favicon imagepatents.justia.com

Perturbation Beads for Use in Assays

October 1, 2024

A patent application for perturbation bead technology, with Zafrens Inc. listed as the applicant.

Favicon imagepatents.justia.com

METHOD FOR EPITOPE BINNING OF NOVEL MONOCLONAL ANTIBODIES

April 1, 2024

A patent application detailing a method for epitope binning of new monoclonal antibodies.

Favicon imagepatents.justia.com

ENRICHMENT OF NUCLEIC ACID SEQUENCES

September 1, 2023

A patent application regarding methods for enriching specific nucleic acid sequences.

Favicon imagepatents.justia.com

Rapid single B cell antibody discovery using nanopens and structured light

January 1, 2019

Describes a direct, flexible, and rapid nanofluidic optoelectronic single B lymphocyte antibody screening technique (NanOBlast) applied to generate anti-idiotypic reagent antibodies using Berkeley Lights' Beacon system.

Favicon imagetandfonline.com

A map of human genome variation from population-scale sequencing

January 1, 2010

A publication from The 1000 Genomes Project, providing a deep characterization of human genome sequence variation.

Favicon imagenature.com

Binding studies between CUGBP1ab and (GTCT) oligonucleotide repeats

May 1, 2007

A conference paper exploring the binding characteristics of CUGBP1ab with specific oligonucleotide repeats.

Favicon imageresearchgate.net

Forecasting production of Hydantoinase in a fed batch fermentor using back propagation neural network modeling technique

A research paper describing the use of a neural network model to predict biomass production in a fed-batch fermentor.

Favicon imageresearchgate.net